Accelerometry-derived activity fragmentation as a predictor of brain atrophy and disability progression in multiple sclerosis

加速度计衍生的活动碎片化可作为多发性硬化症脑萎缩和残疾进展的预测指标

阅读:1

Abstract

BACKGROUND: Accelerometry-derived activity fragmentation reflects how frequently active periods are interrupted by sedentary periods. It has been associated with frailty, mortality, and fatigability in the general population; however, its prognostic significance in multiple sclerosis (MS) remains unknown. OBJECTIVES: To examine whether activity fragmentation is associated with disability progression and brain atrophy in MS. METHODS: People with MS (PwMS) wore wrist tri-axial accelerometers at 3-month intervals, underwent disability assessments biannually, and underwent magnetic resonance imaging (MRI) brain approximately annually. We evaluated whether active-to-sedentary transition probability (ASTP) during the 10 most active hours of each 24-hour period (M10) was associated with outcomes, by modeling between- and within-person effects. RESULTS: Among 238 PwMS, 120 had confirmed Expanded Disability Status Scale (EDSS)-plus progression over a mean of 2.9 ± 1.1 years. Within-person increase in ASTP slope during M10 (indicating increasing activity fragmentation throughout M10) was associated with higher risk of subsequent EDSS-plus progression (per 1 standard deviation (SD) increase: hazard ratio (HR) = 1.21 [95% confidence interval (CI):1.00, 1.45], p = 0.05) and lower deep gray matter and thalamic volumes over time (per 1 SD increase: -0.34 [95% CI: -0.56, -0.12], p = 0.003; -0.40 [95% CI: -0.67, -0.13], p = 0.004, respectively). CONCLUSION: Within-person worsening in activity fragmentation was associated with higher risk of neurologic decline. Activity fragmentation may represent an early compensatory strategy for reduced physiologic reserve and serve as an early indicator of MS progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。